Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation Joshua C. Grimm, MD, Christopher.

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

What Predicts Long-Term Survival After Heart Transplantation

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Lung Transplant Mortality Is Improving in Recipients With a Lung Allocation Score in the Upper Quartile Todd C. Crawford, MD, Joshua C. Grimm, MD, J.

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

SynCardia Temporary Total Artificial Heart as Bridge to Transplantation: Current Results at La Pitié Hospital Matthias E.W. Kirsch, MD, PhD, Anthony.

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Berlin Heart EXCOR Ventricular Assist Device: Multilayer Membrane Rupture in a Pediatric Patient Arianna Di Molfetta, PhD, Sergio Filippelli, PhD, Gianfranco.

Laura Harvey, MD, Christopher Holley, MD, Samit S

Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life Janne J. Jokinen, MD, Anu K. Turpeinen,

Dhaval Chauhan, MD, Alexis K

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Complications After Cardiac Operations: All Are Not Created Equal

The Effect of Institutional Volume on Complications and Their Impact on Mortality After Pediatric Heart Transplantation Cecillia Lui, MD, Joshua C. Grimm,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

The Survival Benefit of Simultaneous Heart-Kidney Transplantation Extends Beyond Dialysis-Dependent Patients Arman Kilic, MD, Joshua C. Grimm, MD, Glenn.

Venous Thromboembolic Complications of Lung Transplantation: A Contemporary Single-Institution Review Charles F. Evans, MD, Aldo T. Iacono, MD, Pablo.

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C

Joshua C. Grimm, MD, J. Trent Magruder, MD, Rika Ohkuma, MD, Samuel P

Who Do You Say You Are? The Annals of Thoracic Surgery

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C.

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Ventricular assist device programs: design and function

Todd C. Crawford, MD, J. Trent Magruder, MD, Joshua C

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

The Impact of Dominant Ventricle Morphology on Palliation Outcomes of Single Ventricle Anomalies Bahaaldin Alsoufi, MD, Scott Gillespie, MS, Dennis Kim,

Left Ventricular Assist Device Destination Therapy Versus Extended Criteria Cardiac Transplant Mani A. Daneshmand, MD, Keshava Rajagopal, MD, PhD, Brian.

Left Ventricular Assist Device Inflow Angle and Pump Positional Change Over Time Adverse Impact on Left Ventricular Assist Device Function Toshinobu.

Outcomes and Costs for Major Lung Resection in the United States: Which Patients Benefit Most From High-Volume Referral? Elliot Wakeam, MD, MPH, Joseph.

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Development and Validation of a Score to Predict the Risk of Readmission After Adult Cardiac Operations Arman Kilic, MD, Jonathan T. Magruder, MD, Joshua.

Patrick O. Myers, MD, Pedro J. del Nido, MD, Gerald R

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Low-Dose Prophylactic Intravenous Immunoglobulin Does Not Prevent HLA Sensitization in Left Ventricular Assist Device Recipients Stavros G. Drakos, MD,

Trends in the Indications and Survival in Pediatric Heart Transplants: A 24-year Single- Center Experience in 307 Patients Rochus K. Voeller, MD, Deirdre.

Michiaki Imamura, MD, PhD, Amy M

Acute Kidney Injury Increases Mortality After Lung Transplantation

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

Right Heart Dysfunction After Left Ventricular Assist Device Implantation: A Comparison of the Pulsatile HeartMate I and Axial-Flow HeartMate II Devices

Adriaan W. Schneider, MD, Nico A. Blom, MD, PhD, Eline F

John F. Lazar, MD, Michael F. Swartz, PhD, Matthew P

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device Palak Shah, MD, MS, Francis D. Pagani, MD, PhD,

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival Simon Maltais, MD, PhD, Nikhil P. Jaik,

Francisco A. Arabía, MD, MBA, Carmelo A

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device Implantation Justin M. Schaffer, MS, George J. Arnaoutakis,

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation Joshua C. Grimm, MD, Vicente Valero, MD, Arman.

The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Nathan Wm. Skelley, BS, Jeremiah.

Increased Mortality at Low-Volume Orthotopic Heart Transplantation Centers: Should Current Standards Change? Eric S. Weiss, MD, Robert A. Meguid, MD,

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

A Risk Score to Predict Acute Renal Failure in Adult Patients After Lung Transplantation Joshua C. Grimm, MD, Cecillia Lui, BSE, Arman Kilic, MD, Vicente.

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Use of Ventricular Assist Devices in Children Across the United States: Analysis of 7.5 Million Pediatric Hospitalizations David L.S. Morales, MD, Farhan.

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Costs Associated With Ventricular Assist Device Use in Children

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Body Mass Index and Outcome After Ventricular Assist Device Placement

Presentation transcript:

Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation Joshua C. Grimm, MD, Christopher M. Sciortino, MD, PhD, J. Trent Magruder, MD, Samuel P. Dungan, BA, Vicente Valero, MD, Kavita Sharma, MD, Ryan J. Tedford, MD, Stuart D. Russell, MD, Glenn J.R. Whitman, MD, Scott C. Silvestry, MD, Ashish S. Shah, MD The Annals of Thoracic Surgery Volume 102, Issue 1, Pages 102-108 (July 2016) DOI: 10.1016/j.athoracsur.2016.01.019 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Differences in the absolute number of devices implanted over the study period. There was a significant increase in left ventricular assist devices (LVADs; black bars) and total artificial hearts (TAHs; light gray), whereas biventricular assist devices (BiVADs, dark gray) remained constant. The Annals of Thoracic Surgery 2016 102, 102-108DOI: (10.1016/j.athoracsur.2016.01.019) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Unconditional survival at 5 years stratified by type of support. Left ventricular assist device (LVAD, dash line) patients demonstrated improved survival (log-rank p < 0.001), mostly as a result of increased early death in biventricular assist device (BiVAD, solid line) and total artificial heart (TAH, dotted line) patients. The Annals of Thoracic Surgery 2016 102, 102-108DOI: (10.1016/j.athoracsur.2016.01.019) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions